Pfizer is committed to finding technology solutions that will improve treatment adherence for patients who require dialysis.
This is the eighth e-Dea Salud Challenge launched by the Pfizer Foundation in collaboration with FPGIBGS and FINIBIC. Its objective is to find alternative and original solutions to empower patients, improve their commitment and adherence to treatment.
The Pfizer Foundation has launched the 8th edition of the e-Dea Salud Challenge in collaboration with the Galician Public Foundation for Biomedical Research Galicia Sur (FPGIBGS) and the Galician Public Foundation for Biomedical Research INIBIC (FINIBIC), which in this edition consists of finding technological solutions to improve adherence to treatment, … + read more
SEFH celebrates 14th Commitment Day with outreach activities
The motto “Increase your adherence…Acquire health” aims to raise awareness of the importance of proper adherence to treatment regimens to achieve the therapeutic goal. + read more
SEDISA and Pfizer collaborate to achieve excellence in healthcare manager professionalization.
The main goal of this collaboration is to improve the quality of public health care by training managers so that they can adapt to a system that is constantly changing and evolving. + read more
Nicolas Garnier, Servier’s new Chief Patient Officer
Nicolas Garnier has been appointed chief patient officer of pharmaceutical group Servier, replacing Bertrand Renaud. + read more
Pfizer, the Pfizer Foundation and Wayra join forces to find the most innovative entrepreneurs.
The fifth edition of Innomakers4health is looking for 100 new participants who will develop a unique solution in 48 hours that will address the challenge posed by the use of technology to manage cardiovascular disease. + read more
CHMP positive opinion on Pfizer RSV vaccine candidate
Pfizer’s RSV vaccine candidate, RSVpreF, will help address the significant burden of RSV disease in people aged 60 years and older and in infants from birth to six months. + read more
Mediterranean diet before breast cancer diagnosis improves prognosis
The survival advantage persists in postmenopausal patients and is even higher in metastatic disease. + read more